NASDAQ:LOXO

Loxo Oncology SEC Filings & 10K Form

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume400 shs
Average Volume565,561 shs
Market Capitalization$7.18 billion
P/E RatioN/A
Dividend YieldN/A
Beta2.51

Loxo Oncology (NASDAQ:LOXO) SEC Filings

DateFilerForm TypeView
01/08/2020
2:11 PM
Loxo Oncology (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/25/2019
10:28 AM
Loxo Oncology (Filer)
Form 15-12B
02/21/2019
11:15 PM
Loxo Oncology (Filer)
Form EFFECT
02/15/2019
3:55 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:51 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:49 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:47 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:46 PM
Loxo Oncology (Filer)
Form S-8 POS
02/15/2019
3:41 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/15/2019
3:39 PM
Loxo Oncology (Filer)
Form POSASR
02/15/2019
3:36 PM
Loxo Oncology (Filer)
Form POS AM
02/15/2019
3:05 PM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
02/15/2019
8:23 AM
Loxo Oncology (Subject)
Form SC 14D9/A
02/15/2019
8:20 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T/A
02/15/2019
8:18 AM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:17 AM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:16 AM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:15 AM
Loxo Oncology (Subject)
The Nasdaq Stock Market LLC (Filed by)
Form 25-NSE
02/15/2019
8:14 AM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:14 AM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:13 AM
Harr Steve (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:12 AM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:11 AM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:09 AM
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:07 AM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/15/2019
8:06 AM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2019
12:51 PM
Loxo Oncology (Subject)
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Form SC 13G/A
02/13/2019
1:08 PM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/12/2019
8:58 AM
Loxo Oncology (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/11/2019
12:59 PM
Loxo Oncology (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/11/2019
8:14 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/08/2019
11:33 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/06/2019
2:03 PM
BlackRock Inc. (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
02/05/2019
3:00 PM
Loxo Oncology (Subject)
Form SC 14D9/A
02/01/2019
6:18 AM
Loxo Oncology (Subject)
Form SC 14D9/A
02/01/2019
6:16 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T/A
01/17/2019
7:08 AM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4/A
01/17/2019
7:06 AM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4/A
01/17/2019
6:37 AM
Loxo Oncology (Subject)
Form SC 14D9
01/17/2019
6:35 AM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-T
01/15/2019
3:08 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC 13D
01/15/2019
7:30 AM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
01/10/2019
2:25 PM
Loxo Oncology (Subject)
SANDS CAPITAL MANAGEMENT, LLC (Filed by)
Form SC 13G/A
01/08/2019
4:08 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-C
01/07/2019
4:09 PM
Loxo Oncology (Subject)
Form SC14D9C
01/07/2019
1:59 PM
LILLY ELI & CO (Filed by)
Loxo Oncology (Subject)
Form SC TO-C
01/07/2019
6:14 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2019
4:08 PM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:06 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:04 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:03 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/02/2019
4:02 PM
Loxo Oncology (Issuer)
Nanda Nisha (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/02/2019
3:30 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2018
4:07 PM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:17 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:14 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2018
4:12 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2018
3:30 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2018
4:13 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
4:09 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/28/2018
4:08 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2018
5:01 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2018
3:31 PM
Loxo Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2018
5:45 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/05/2018
3:46 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:44 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/05/2018
3:42 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2018
5:45 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/14/2018
5:19 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
5:17 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
5:14 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:27 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:25 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2018
4:23 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2018
3:39 PM
Loxo Oncology (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/09/2018
3:03 PM
Loxo Oncology (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/09/2018
5:46 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2018
3:45 PM
AISLING CAPITAL III LP (Filed by)
Loxo Oncology (Subject)
Form SC 13D/A
07/12/2018
3:45 PM
AISLING CAPITAL III LP (Reporting)
Aisling Capital Partners III LLC (Reporting)
Aisling Capital Partners III LP (Reporting)
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Purcell Dennis J (Reporting)
SCHIFF ANDREW N (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:04 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:03 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2018
4:01 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2018
9:52 AM
FMR LLC (Filed by)
Loxo Oncology (Subject)
Form SC 13G/A
06/21/2018
4:04 PM
Burstein Jennifer (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:03 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2018
4:02 PM
Bilenker Joshua H. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2018
4:00 PM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:10 PM
Loxo Oncology (Issuer)
Naider Avi Z. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:07 PM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:05 PM
Kunkel Lori Anne (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:04 PM
Harr Steve (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:03 PM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:02 PM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:01 PM
ELMS STEVE (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2018
4:00 PM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2018
5:02 PM
Loxo Oncology (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
5:01 PM
Fuhrman Alan (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2018
5:00 PM
Flaherty Keith T. (Reporting)
Loxo Oncology (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2018
5:46 AM
Loxo Oncology (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2018
3:46 PM
Loxo Oncology (Issuer)
Van Naarden Jacob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 8/1/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.